Skip to content
Pre-IVF Mandatory Tests
IVF

Pre-IVF Mandatory Tests

Specialist physician: Assist. Prof. Dr. Muzaffer Uçarer — Obstetrics & Gynaecology · IVF and Reproductive Medicine  ·  Last updated: June 2026
This page provides general information and does not replace a medical consultation. Please consult your physician about your individual situation.

Before starting IVF treatment, both partners undergo a comprehensive set of tests to ensure safety, optimize the treatment plan, and identify any factors that may affect outcomes. These tests evaluate hormonal balance, infectious status, anatomical findings, and where indicated, genetic factors.

Important Information

  • Female panel typically includes hormonal tests (FSH, LH, AMH, E2, TSH, Prolactin), pelvic ultrasound, and infection screening (HIV, HBV, HCV, syphilis, rubella).
  • Male panel includes spermiogram and infection screening; additional tests may be added based on findings.
  • For couples with recurrent loss or specific history, additional tests such as karyotype or thrombophilia panel may be requested.
  • Many tests are timed to specific days of the menstrual cycle for accurate interpretation.

Our Approach

Dr. Muzaffer focuses on the underlying biological response rather than age alone, using test results to design a personalized IVF protocol for each patient.

Prices

  • Female — €400
  • Male — €300

Our medical prices are fixed; your exact, all-inclusive price is confirmed in writing after your consultation. See our full price list →

Contact UCARER Women’s Health to book your consultation with Assist. Prof. Dr. Muzaffer Uçarer.

Explore More

IVF

EmbryoGlue

EmbryoGlue is a specialized embryo transfer medium enriched with hyaluronan, a natural component of the female reproductive tract. It is designed to mimic the uterine environment at the time of…

Learn More — EmbryoGlue

Frequently Asked Questions

Common Questions

Most tests are completed within 1–2 weeks. Some hormonal tests must be timed to specific days of the menstrual cycle, which may extend the timeline slightly.

Yes, recent valid results from accredited laboratories are usually accepted. Some tests may need to be repeated locally according to clinic and regulatory requirements.

Hormonal tests (especially day-2/3 hormones) and selected infection screenings are repeated to ensure they reflect current status.

Yes. Low AMH indicates reduced ovarian reserve, but biological response varies between individuals. Treatment plans are tailored accordingly, with realistic counseling about expectations.

No. Karyotyping is typically requested in cases of recurrent miscarriage, repeated IVF failure, or family history suggesting a genetic factor.

Book Your Appointment Today

We provide a comfortable environment where you can consult us with all your problems in the field of Obstetrics, Gynecology and IVF Treatment.

Book Now Chat on WhatsApp